Differential impact of infection control strategies on rates of resistant hospital-acquired pathogens in critically ill surgical patients

Surgical Infections

Volumn 15, Issue 6, 2014, Pages 726-732

  Jayaraman, Sudha P ^a   Askari, Reza ^b   Bascom, Molli ^b   Liu, Xiaoxia ^b   Rogers, Selwyn O ^c   Klompas, Michael ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CRITICALLY ILL PATIENT; ENTEROCOCCAL INFECTION; FEMALE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; RETROSPECTIVE STUDY; SURGICAL INFECTION; SURGICAL PATIENT; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIUM; CRITICAL ILLNESS; CROSS INFECTION; DRUG EFFECTS; EPIDEMIC; GRAM-POSITIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTIDRUG RESISTANCE; PROCEDURES; UNIVERSITY HOSPITAL;

BACTERIA; CRITICAL ILLNESS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INFECTION CONTROL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84918538651     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2013.265     Document Type: Article

References (32)

1. Jones RN. Resistance patterns among nosocomial pathogens: Trends over the past few years. Chest 2001;119 (2 Suppl):397S-404S.
2. Scott RD. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. (Publication No. CS200891-A). Centers for Disease Control and Prevention, 2009.
3. Mauldin PD, Salgado CD, Hansen IS, et al. Attributable hospital cost and length of stay associated with health careassociated infections caused by antibiotic-resistant gramnegative bacteria. Antimicrob Agents Chemother 2010;54: 109-115.
4. Lee NY, Lee HC, Ko NY, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007;28:713-719.
5. Young LS, Sabel AL, Price CS. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect Control Hosp Epidemiol 2007;28:1247-1254.
6. Gould IM, Reilly J, Bunyan D, et al. Costs of healthcareassociated methicillin-resistant Staphylococcus aureus and its control. Clin Microbiol Infect 2010;16:1721-1728.
7. Goetghebeur M, Landry PA, Han D, et al. Methicillin-resistant Staphylococcus aureus: A public health issue with economic consequences. Can J Infect Dis Med Microbiol 2007;18:27-34.
8. Filice GA, Nyman JA, Lexau C, et al. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infect Control Hosp Epidemiol 2010;31:365-373.
9. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006;42(Suppl 2): S82-89.
10. Pacheco SM, Johnson S. Important clinical advances in the understanding of Clostridium difficile infection. Curr Opin Gastroenterol 2013;29:42-48.
11. Petrella LA, Sambol SP, Cheknis A, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 2012;55:351-357.
12. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012;55(Suppl 2): S88-92.
13. OBrien JA, Lahue BJ, Caro JJ, et al. The emerging infectious challenge of clostridium difficile-Associated disease in Massachusetts hospitals: Clinical and economic consequences. Infect Control Hosp Epidemiol 2007;28:1219-1227.
14. Eberle BM, Schnuriger B, Putty B, et al. The impact of Acinetobacter baumannii infections on outcome in trauma patients: A matched cohort study. Crit Care Med 2010; 38:2133-2138.
15. Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-Acquired infection. N Engl J Med 2013;368:533-542.
16. Goodman ER, Platt R, Bass R, et al. Impact of an environmental cleaning intervention on the presence of methicillinresistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 2008;29:593-599.
17. Huang SS, Datta R, Platt R. Risk of acquiring antibioticresistant bacteria from prior room occupants. Arch Intern Med 2006;166:1945-1951.
18. Datta R, Platt R, Yokoe DS, et al. Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med 2011; 171:491-494.
19. Morgan DJ, Rogawski E, Thom KA, et al. Transfer of multidrug-resistant bacteria to healthcare workers gloves and gowns after patient contact increases with environmental contamination. Crit Care Med 2012;40:1045-1051.
20. Passaretti CL, Otter JA, Reich NG, et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis 2013;56:27-35.
21. Rosenberger LH, Hranjec T, Politano AD, et al. Effective cohorting and 'superisolation in a single intensive care unit in response to an outbreak of diverse multi-drug-resistant organisms. Surg Infect 2011;12:345-350.
22. La Forgia C, Franke J, Hacek DM, et al. Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: A 38-month report. Am J Infect Control 2010;38:259-263.
23. Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012;4:148ra16.
24. Piednoir E, Thibon P, Borderan GC, et al. Long-Term clinical and economic benefits associated with the management of a nosocomial outbreak resulting from extendedspectrum beta-lactamase-producing Klebsiella pneumoniae. Crit Care Med 2011;39:2672-2677.
25. Huskins WC, Huckabee CM, OGrady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011;364:1407-1418.
26. Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-Acquired infection. N Engl J Med 2013;368:533-542.
27. Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-Associated bloodstream infections: Results of a quasi-experimental multicenter trial. Crit Care Med. 2009;37:1858-1865.
28. Becher RD, Hoth JJ, Neff LP, et al. Multidrug-resistant pathogens and pneumonia: Comparing the trauma and surgical intensive care units. Surg Infect 2011;12:267-272.
29. Hedrick TL, Smith RL, McElearney ST, et al. Differences in early-And late-onset ventilator-Associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit. J Trauma 2008;64:714-720.
30. Magret M, Amaya-Villar R, Garnacho J, et al. Ventilatorassociated pneumonia in trauma patients is associated with lower mortality: Results from EU-VAP study. J Trauma 2010;69:849-854.
31. Hedrick TL, Smith RL, McElearney ST, et al. Differences in early-And late-onset ventilator-Associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit. J Trauma 2008;64:714-720.
32. Jayaraman S, Klompas M, Bascom M, et al. Hand hygiene compliance does not predict rates of resistant infections in critically ill surgical patients. Surg Infect 2014;15:533-539.